Related Experiment Videos
[Inhalation therapy of antibiotics]
Y Noguchi1, M Taguchi, M Takasugi
1Respiratory Clinic, Saitama Cancer Center, Japan.
Nihon Kyobu Shikkan Gakkai Zasshi
|November 1, 1990
Summary
Aerosolized antibiotics, including cefazolin and gentamicin, effectively treated experimental Klebsiella pneumoniae pneumonia in mice. Low-level inhalation therapy with cephems shows promise for bacterial respiratory infections.
Area of Science:
- Microbiology
- Pharmacology
- Pulmonology
Background:
- Klebsiella pneumoniae pneumonia is a significant respiratory infection.
- Antibiotic therapy is crucial for treating bacterial pneumonia.
- Optimizing antibiotic delivery to the lungs is essential for efficacy.
Purpose of the Study:
- To evaluate the efficacy of aerosolized cefazolin and gentamicin in a murine model of Klebsiella pneumoniae pneumonia.
- To determine the optimal dosage and delivery method for inhaled antibiotics.
- To assess the potential of inhalation therapy for bacterial respiratory infections.
Main Methods:
- Experimental pneumonia was induced in mice via airborne Klebsiella pneumoniae.
- Minimum inhibitory concentrations (MICs) for cefazolin and gentamicin were determined.
- Mice were treated with varying doses of aerosolized gentamicin and cefazolin via inhalation.
- Survival rates and clinical effects were monitored.
Main Results:
- Gentamicin demonstrated a low MIC (0.39 µg/ml) and was effective at various inhaled doses.
- Cefazolin had a higher MIC (1.56 µg/ml) but showed high survival rates at 50 mg/ml (500 mg total dose).
- Inhalation therapy with 50 mg/ml cefazolin reached the alveoli, and cephem inhalation showed clinical efficacy in chronic bronchitis.
Conclusions:
- Aerosolized cefazolin at 50 mg/ml is effective in treating experimental Klebsiella pneumoniae pneumonia.
- Low-level inhalation therapy with cephems is a suitable treatment for bacterial respiratory infections.
- Inhaled cephem therapy demonstrates significant clinical benefits for chronic bronchitis.